◀ Back to CDK2
CCNH — CDK2
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Biogrid Interaction:
CCNH
—
CDK2
(direct interaction, enzymatic study)
Garrett et al., Mol Cell Biol 2001*
-
IRef Biogrid Interaction:
CCNH
—
CDK2
(direct interaction, enzymatic study)
Higashi et al., Eur J Biochem 1996
-
IRef Biogrid Interaction:
CCNH
—
CDK2
(direct interaction, enzymatic study)
Xu et al., Biochemistry 1999*
-
IRef Biogrid Interaction:
CCNH
—
CDK2
(direct interaction, enzymatic study)
Lolli et al., Structure 2004*
-
IRef Biogrid Interaction:
CCNH
—
CDK2
(physical association, affinity chromatography technology)
Varjosalo et al., Nat Methods 2013
-
IRef Hprd Interaction:
CCNH
—
CDK2
(in vitro)
Mandal et al., Oncogene 1998*
-
IRef Intact Interaction:
CCNH
—
CDK2
(physical association, two hybrid)
Zariwala et al., Oncogene 1998
-
IRef Intact Interaction:
Complex of MNAT1-CDK7-CCNH-CDK2
(phosphorylation reaction, protein kinase assay)
Tassan et al., EMBO J 1995*
-
IRef Ophid Interaction:
CCNH
—
CDK2
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Morisaki et al., Exp Cell Res 1999
:
This cyclin D1-bound
Cdk2 was not
activated by
CAK either in vivo or in vitro, implicating cyclin D1 as an inhibitor of Cdk2 activation
Kim et al., J Biol Chem 2001
:
For example, CDK9 was not phosphorylated by CAK, whereas
CDK2-cyclin A kinase activity was dramatically
enhanced by
CAK
Yao et al., Mol Cell Biol 2002
:
Activation of the Bur1-Bur2
cyclin dependent kinase complex by
Cak1
Hamada et al., Biochim Biophys Acta 1996
:
Phorbol ester treatment does not reduce the protein level of
p33CDK2 , but does
inhibit serum stimulated increases in the
CAK activity and CDK2 phosphorylation at Thr160
Ko et al., Mol Cell Biol 1997
:
While
CDK7-cyclin H is
sufficient for phosphorylation of
CDK2 , we show that p36MAT1 is required for efficient phosphorylation of p53 by CDK7-cyclin H, suggesting that p36MAT1 can act as a substrate specificity determining factor for CDK7-cyclin H
Mandal et al., Oncogene 1998
:
We also demonstrated that IFN induced CKIs prevent CAK from activating the CDK-2 as immunodepletion of induced CKIs from the inhibitory extracts resulted in the restoration of
CAK mediated activation of
CDK-2